Understanding of metastatic colorectal cancer (mCRC) in the real world: Initial results from a European survey on the unmet needs of patients living with metastatic colorectal cancer

被引：0
|
作者：
Maravic, Z. [1 ]
Wyrwicz, L. [2 ]
Karczmarek-Borowska, B. [3 ]
Basany, E. Espin [4 ]
Carrato, A. [5 ]
Horvath, A. [6 ]
aBenedict [7 ]
Kapitany, Z. [8 ]
机构：
[1] EuropaColon, Salisbury, Wilts, England
[2] Ctr Onkol Inst M Sklodowskiej Curie, Warsaw, Poland
[3] Ctr Clin Oncol Prov Hosp 1, Rzeszow, Poland
[4] Univ Autonoma Barcelona, Hosp Valle de Hebron, Barcelona, Spain
[5] Alcala Univ, Hosp Univ Ramon y Cajal, CIBERONC, IRYCIS, Madrid, Spain
[6] Semmelweis Univ, Budapest, Hungary
[7] Evidera, Budapest, Hungary
[8] Semmelweis Univ, Fac Hlth Sci, Budapest, Hungary
来源：
ANNALS OF ONCOLOGY | 2018年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P - 272
引用
收藏
页码：77 / 77
页数：1
相关论文
共 50 条
  • [21] Survival outcomes in US patients with metastatic colorectal cancer (mCRC)
    Knopf, Kevin
    Iqbal, Sheikh Usman
    Thompson, Stephen F.
    Malangone, Elisabetta
    Gorritz-Kindu, Magdaliz
    Stern, Lee
    Sherman, Steven A.
    Naoshy, Sarah
    Wooten, Michael
    Andria, Michael L.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (04)
  • [22] Predictors of treatment attrition in patients with metastatic colorectal cancer (mCRC).
    Bahrabadi, Arvin
    Ruan, Jenny
    Gresham, Gillian
    Cheung, Winson Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [23] Survival for patients with resectable lung metastatic colorectal cancer (mCRC).
    Price, Timothy Jay
    Tomita, Yoko
    Beeke, Carol
    Padbury, Robert
    Townsend, Amanda Rose
    Maddern, Guy
    Roy, Amitesh
    Roder, David
    Karapetis, Christos Stelios
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
  • [24] Initial correlative studies from a trial of cetuximab and pembrolizumab in metastatic colorectal cancer (mCRC).
    Boland, Patrick M.
    Muhitch, Jason
    Abrams, Scott, I
    Maguire, Orla
    Minderman, Hans
    Bajor, David Lawrence
    Saltzman, Joel N.
    Wang, Katy
    Hutson, Alan
    Mukherjee, Sarbajit
    Iyer, Renuka, V
    Kalinski, Pawel
    Fountzilas, Christos
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [25] NEW INSIGHTS IN METASTATIC COLORECTAL CANCER TREATMENT (MCRC) IN 5 EUROPEAN COUNTRIES
    Kolb, N.
    Reichert, A.
    Menacher, G.
    Mambrini, T.
    von Bredow, D.
    VALUE IN HEALTH, 2017, 20 (09) : A464 - A464
  • [26] Real-world BRAF testing patterns for patients with metastatic colorectal cancer (mCRC), metastatic melanoma, and non-small cell lung cancer (NSCLC).
    Edwards, Michelle L.
    Levin, Rebecca
    Abraham, Anup
    Amari, Diana T.
    Kelton, John M.
    Vieira, Maria Cecilia
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [27] Real-world dosing of regorafenib (REG) in metastatic colorectal cancer (mCRC): Final results from the prospective, observational CORRELATE study
    O'Connor, J. M.
    Ducreux, M.
    Petersen, L. N.
    Oehler, L.
    Bergamo, F.
    Metges, J-P.
    de Groot, J. W.
    Wang, J-Y.
    Garcia Paredes, B.
    Dochy, E.
    Fiala-Buskies, S.
    Cervantes, A.
    Falcone, A.
    ANNALS OF ONCOLOGY, 2018, 29
  • [28] Treatment patterns and outcomes in metastatic colorectal cancer (mCRC).
    Cartwright, Thomas H.
    Wen, Lonnie Kent
    Harrell, Robyn K.
    Fox, Patricia S.
    Espirito, Janet L.
    Wang, Ed
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)
  • [29] Predictors of attrition in the treatment of metastatic colorectal cancer (MCRC).
    Bahrabadi, Arvin
    Ruan, Jenny
    Gresham, Gillian
    Cheung, Winson Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [30] Treatment of elderly patients with metastatic colorectal cancer (MCRC): Our experience
    Longo, F.
    Proietti, E.
    Raimondi, C.
    Graziano, V
    Zivi, A.
    Sacco, P.
    Cerbone, I
    Russillo, M.
    Restuccia, M.
    di Seri, M.
    ANNALS OF ONCOLOGY, 2006, 17 : 74 - 74
12345